Maryam Oroujeni

18PUBLICATIONS
24CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersMolecular targetsMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Feb 27, 2026
Efficient 68Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model.

Vladimir Tolmachev, Amelinda Janice Herlina, Eleftherios Papalanis

|Oct 16, 2025
Preclinical Positron Emission Tomography Imaging of B7-H3 Expression Using Affibody Molecules Labeled with Gallium-68.

Vladimir Tolmachev, Ekaterina A Bezverkhniaia, Eleftherios Papalanis

|Jun 13, 2025
Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular Architecture.

Vladimir Tolmachev, Anzhelika Vorobyeva, Alia Hani Binti Rosly

|May 30, 2025
Selection of the optimal chelator for labeling of DARPin Ec1 with gallium-68 for PET imaging of EpCAM expression.

Anzhelika Vorobyeva, Moeen-Ud Din, Alexey Schulga

|Mar 20, 2025
Impact of Radiometal Chelates on In Vivo Visualization of Immune Checkpoint Protein Using Radiolabeled Affibody Molecules.

Vladimir Tolmachev, Eleftherios Papalanis, Ekaterina A Bezverkhniaia

|Apr 27, 2024
Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion.

Sergey M Deyev, Maryam Oroujeni, Javad Garousi

Pageof 3

Frequent Collaborators

16 joint publications

Anna Orlova

16 joint publications

Vladimir Tolmachev

12 joint publications

Anzhelika Vorobyeva

7 joint publications

Tianqi Xu